Trials / Conditions / MET Exon 14 Mutation
MET Exon 14 Mutation
3 registered clinical trials studyying MET Exon 14 Mutation — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previ NCT06908993 | Intergroupe Francophone de Cancerologie Thoracique | Phase 3 |
| Not Yet Recruiting | Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung C NCT07153770 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |
| Not Yet Recruiting | Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations NCT06054191 | Sun Yat-sen University | Phase 2 |